Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anirban Basu

Showing results (11-20 of 471) with videos related to

Pageof 48
Sort By:
Forum for Health Economics & Policy|August 18, 2019
Personalized Medicine in the Context of Comparative Effectiveness ResearchAnirban Basu
Science Advances|May 26, 2023
Use of race in clinical algorithmsAnirban Basu
Health Economics|August 3, 2018
Comment: Manski's views on patient care under uncertaintyAnirban Basu
Statistics in Biosciences|October 20, 2011
Estimating Decision-Relevant Comparative Effects Using Instrumental VariablesAnirban Basu
Health Affairs (Project Hope)|August 4, 2020
COVID-19 Infection Fatality Rates: The Author RepliesAnirban Basu
Journal of Applied Econometrics (Chichester, England)|January 27, 2015
ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTSAnirban Basu
Journal of Health Economics|May 13, 2015
Welfare implications of learning through solicitation versus diversification in health careAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Cost-effectiveness of olanzapine as a first-line treatment: a commentAnirban Basu
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Irrelevance of explicit cost-effectiveness thresholds when coverage decisions can be reversedAnirban Basu
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 27, 2009
Forecasting distribution of body mass index in the United States: is there more room for growth?Anirban Basu
Pageof 48

Showing results (11-20 of 471) with videos related to

Sort By:
Pageof 48
Forum for Health Economics & Policy|August 18, 2019
Personalized Medicine in the Context of Comparative Effectiveness ResearchAnirban Basu
Science Advances|May 26, 2023
Use of race in clinical algorithmsAnirban Basu
Health Economics|August 3, 2018
Comment: Manski's views on patient care under uncertaintyAnirban Basu
Statistics in Biosciences|October 20, 2011
Estimating Decision-Relevant Comparative Effects Using Instrumental VariablesAnirban Basu
Health Affairs (Project Hope)|August 4, 2020
COVID-19 Infection Fatality Rates: The Author RepliesAnirban Basu
Journal of Applied Econometrics (Chichester, England)|January 27, 2015
ESTIMATING PERSON-CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTSAnirban Basu
Journal of Health Economics|May 13, 2015
Welfare implications of learning through solicitation versus diversification in health careAnirban Basu
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 12, 2006
Cost-effectiveness of olanzapine as a first-line treatment: a commentAnirban Basu
Expert Review of Pharmacoeconomics & Outcomes Research|April 11, 2013
Irrelevance of explicit cost-effectiveness thresholds when coverage decisions can be reversedAnirban Basu
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 27, 2009
Forecasting distribution of body mass index in the United States: is there more room for growth?Anirban Basu
Pageof 48